Future of Hyponatremia Research.

2区医学 Q2 Medicine

Frontiers of Hormone Research Pub Date : 2019-01-01 Epub Date: 2019-01-15 DOI:10.1159/000493249

Joseph G Verbalis, Alessandro Peri, Chris J Thompson

引用次数: 2

Abstract

Despite the many advances made in understanding the manifestations and consequences of hyponatremia, and the availability of effective pharmacologic therapies for the treatment of hyponatremia, it is obvious that we do not yet have a uniformly accepted consensus on how and when this disorder should be treated. To achieve this consensus, additional translational and clinical research will be necessary to establish the knowledge base upon which evidence-based recommendations can be made with confidence.

查看原文本刊更多论文

低钠血症研究的未来。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Frontiers of Hormone Research 医学-内分泌学与代谢

自引率

0.00%

发文量

期刊介绍： A series of integrated overviews on cutting-edge topics New sophisticated technologies and methodological approaches in diagnostics and therapeutics have led to significant improvements in identifying and characterizing an increasing number of medical conditions, which is particularly true for all aspects of endocrine and metabolic dysfunctions. Novel insights in endocrine physiology and pathophysiology allow for new perspectives in clinical management and thus lead to the development of molecular, personalized treatments. In view of this, the active interplay between basic scientists and clinicians has become fundamental, both to provide patients with the most appropriate care and to advance future research.